Skip to main navigation

Close

About Us
Our Science
- Publications
Pipeline
Patients
Investors
Culture & Careers
Contact Us

COVID-19 Information
Privacy Policy
Terms of Use
Do Not Sell My Personal Information

Follow Us

About Us
Our Science
- Publications
Pipeline
Patients
Investors
Culture & Careers
Contact Us

Investor Calendar

Overview
Press Releases
Events and Presentations
Stock Information
- Stock Quote & Chart
- Analyst Coverage
SEC Filings
Governance
Investor Resources

Upcoming Events

More events are coming soon.

Past Events

Jun 18, 2024 at
3:00 PM EDT

Crossing the Blood-Brain Barrier: Advancing the Next Generation of Alector Neurodegenerative Therapies Registration

Click here for webcast

Supporting Materials

Crossing the Blood-Brain Barrier: Developing Alector’s Next Generation of Investigational Therapies for Neurodegeneration 3.8 MB

Presentations

Alector January 2025 Corporate Presentation

Baseline characteristics for INFRONT-3: A Phase 3 double-blind, placebo-controlled 96-week study evaluating latozinemab in FTD-GRN

Exploring quality of life impact reported by caregivers in the FTD Insights Survey

Challenges Facing Caregivers of Individuals Diagnosed With Frontotemporal Dementia in the United States

Baseline characteristics for INVOKE-2: a phase 2 randomized, double-blind, placebo-controlled study evaluating AL002 in early Alzheimer’s disease

Use of a blood-based amyloid test for screening in INVOKE-2: a phase 2 randomized, double-blind, placebo-controlled study evaluating AL002 in early Alzheimer’s disease

PK/PD Modeling of Progranulin Elevation in Blood and CSF to Support AL101 Phase 2 Study

INVOKE-2: An Update on the Phase 2 Trial of AL002 in Early AD

AL002c-mediated Reduction in Amyloid β Pathology is Reflected by Changes in Plasma Alzheimer's Disease Biomarkers in 5xFAD Mice

Repeat IV and SC Dosing of the Anti-Sortilin Antibody AL101

Pagination

Current page 1
Page 2
Next page
Last page

Be the first to hear about our latest discoveries.

About Us
Our Science
- Publications
Pipeline
Patients
Investors
Culture & Careers

Follow Us

COVID-19 Information
Privacy Policy
Terms of Use
Do Not Sell My Personal Information

Copyright Alector, Inc. 2025.

The information regarding our therapeutic candidates and the patients they are intended to treat on this site is intended only for residents of the U.S.

Close

Are you sure you want to leave?

You are about to leave the Alector site. Please note our privacy policy won’t apply to these third-party sites.

Continue

Cancel